Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2023
Jan. 31, 2023
Current assets:    
Cash and cash equivalents $ 172,462 $ 188,387
Marketable securities 483,969 390,239
Accounts receivable, net of allowance of $4.9 million and $3.2 million, respectively 153,660 205,038
Prepaid expenses and other current assets 77,228 78,865
Total current assets 887,319 862,529
Property and equipment, net 30,597 22,885
Goodwill and other intangible assets 50,221 50,349
Operating lease right-of-use assets 27,576 15,725
Other non-current assets 92,001 73,503
Total assets 1,087,714 1,024,991
Current liabilities:    
Accounts payable 22,473 30,101
Accrued expenses and other current liabilities 72,781 97,524
Operating lease liabilities, current 6,208 7,134
Deferred revenue 297,130 324,140
Total current liabilities 398,592 458,899
Deferred revenue, non-current 1,155 1,371
Deferred tax liability, non-current 1,300 1,289
Operating lease liabilities, non-current 23,530 9,633
Other liabilities, non-current 4,933 4,467
Total liabilities 429,510 475,659
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Treasury stock, at cost, 14,130,784 and 14,130,784 shares as of October 31, 2023 and January 31, 2023, respectively (23,831) (23,831)
Additional paid-in capital 1,153,761 1,074,149
Accumulated other comprehensive loss (5,383) (4,384)
Accumulated deficit (466,351) (496,611)
Total stockholders’ equity 658,204 549,332
Total liabilities and stockholders’ equity 1,087,714 1,024,991
Class A    
Stockholders’ equity:    
Common stock 4 3
Class B    
Stockholders’ equity:    
Common stock $ 4 $ 6